Karuna Therapeutics, Inc. (NASDAQ:KRTX) Shares Sold by Hamil

Hamilton Lane Advisors LLC reduced its stake in Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Rating) by 17.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 64,090 shares of the company’s stock after selling 13,196 shares during the period. Karuna Therapeutics accounts […]

Related Keywords

Hong Kong , Boston , Massachusetts , United States , Andrew Craig Miller , Peter Jeffrey Conn , Stephenk Brannan , Eric Elenko , Andrew Miller , Securities Exchange Commission , Almanack Investment Partners , Cantor Fitzgerald , Karuna Therapeutics Inc , Advisors Inc , Nasdaq , Hong Kong Ltd , Hamilton Lane Advisors , Karuna Therapeutics , Get Rating , Lane Advisors , Investment Partners , Kong Ltd , Craig Miller , Visit Holdingschannel , Karuna Therapeutics Daily , Nasdaq Krtx , Krtx , Medical , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,